American Society of Hematology, Blood Advances, 9(3), p. 1546-1552, 2019
DOI: 10.1182/bloodadvances.2019000123
Full text: Download
Key Points FDG-PET–negative status achieved with salvage therapy is the most important determinant of favorable outcome after HSCT, for patients with R/R cHL. Our modified Bv+Bs salvage regimen led to deep metabolic responses in the majority of patients, establishing a bridge to transplant.